ArticleCancers2019

Hyperprogressive Disease during Anti-PD-1 (PDCD1) / PD-L1 (CD274) Therapy: A Systematic Review and Meta-Analysis.

Jong Yeob Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.